Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Oncology | Nephrology | Family Medicine
Kidney Cancer Clinical Trials
A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 Last
Alabama
University of Alabama at Birmingham
A clinical research study of Axitinib for the treatment of Renal Cell Carcinoma
Arizona
Research Site
A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma
Scottsdale Arizona
A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma
Mayo Clinic Scottsdale
A clinical trial to evaluate treatments using hypoxia-activated prodrug TH-302, sorafenib tosylate, protein analysis and laboratory biomarker analysis for patients with Kidney Cancer or Liver Cancer
California
Samuel Oschin Cancer Center at Cedars-Sinai Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
David Geffen School of Medicine at UCLA
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
California Pacific Medical Center Research Institute
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Colorado
The Urology Center of Colorado
Phase II, open-label study evaluating DN24-02 as adjuvant therapy in subjects with high risk HER2+ urothelial carcinoma.
View More »
University of Colorado Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
The Urology Center of Colorado
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Advanced Urology, P.C.
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Connecticut
Hartford Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Florida
MD Anderson - Orlando
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
H. Lee Moffitt Cancer Center & Research Institute
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Georgia
Emory Univeristy Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Taofeek Owonikoko, MD, PhD
Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors
Emory University Winship Cancer Institute
Patients are needed to participate in a clinical research study of Lenalidomide and Everolimus to evaluate Solid Organ Malignancies
Idaho
Saint Alphonsus Regional Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Idaho Urologic Institute
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Illinois
Sherman Health
SWOG S0931 Phase III Randomized Study of Everolimus Versus Placebo in Patients With Renal Cell Carcinoma Who Have Undergone Nephrectomy or Partial Nephrectomy
View More »
Vanguard Health Chicago
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
University of Chicago
A Phase 2 clinical study for patients with Advanced Non-clear Cell Renal Cell Carcinoma
University of Illinois Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Rush University Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Edward Hines Jr VA Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Loyola University Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Edward H. Kaplan and Associates
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Southern Illinois University - Simmons Cancer Institute
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Indiana
Urology of Indiana
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Indiana University Melvin and Bran Simon Cancer Center
A Phase 2 clinical study for patients with Advanced Non-clear Cell Renal Cell Carcinoma
Indiana University Melvin and Bren Simon Cancer Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Franciscan St. Francis Health - Franciscan Physician Network Oncology and Hematology Specialists
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Iowa
University of Iowa Hospital and Clinics
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Kansas
University of Kansas Cancer Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Cancer Center of Kansas
A clinical research study of Axitinib for the treatment of Renal Cell Carcinoma
Kentucky
Jewish Hospital & St. Mary's Healthcare
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Louisiana
East Jefferson General Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Ochsner Clinic Foundation
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Tulane University Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Maryland
Greater Baltimore Medical Center (GBMC)
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
University of Maryland, Greenebaum Cancer Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Massachusetts
Massachusetts General Hospital
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Lahey Clinic Medical Center
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Michigan
Karmanos Cancer Institute/Wayne State University
A Phase 2 clinical study for patients with Advanced Non-clear Cell Renal Cell Carcinoma
Karmanos Cancer Institute - Wayne State University School of Medicine
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Cancer and Hematology Clinics of Western Michigan - Spectrum Health
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Minnesota
University of Minnesota
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
Mayo Clinic Cancer Center
A clinical trial to evaluate treatments using hypoxia-activated prodrug TH-302, sorafenib tosylate, protein analysis and laboratory biomarker analysis for patients with Kidney Cancer or Liver Cancer
Mayo Clinic - Rochester
Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma
First 1 2 3 Last
